131 related articles for article (PubMed ID: 11460014)
21. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
[TBL] [Abstract][Full Text] [Related]
23. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
24. Urinary protein C inhibitor as a therapeutic agent to disseminated intravascular coagulation (DIC): a comparison with low molecular weight heparin in rats with lipopolysaccharide-induced DIC.
Izutani W; Fujita M; Nishizawa K; Koga J
Biol Pharm Bull; 2000 Sep; 23(9):1046-50. PubMed ID: 10993202
[TBL] [Abstract][Full Text] [Related]
25. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
26. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
Tallman MS
Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
[TBL] [Abstract][Full Text] [Related]
27. [Complete remission of acute promyelocytic leukemia accompanied by DIC in an elderly patient treated with all-trans retinoic acid].
Handa H; Jinbo T; Okamoto K; Hirabayashi H; Miyawaki S
Nihon Ronen Igakkai Zasshi; 1993 Feb; 30(2):146-9. PubMed ID: 8483289
[TBL] [Abstract][Full Text] [Related]
28. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
29. miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.
Zhang R; Lu S; Yang X; Li M; Jia H; Liao J; Jing Q; Wu Y; Wang H; Xiao F; Bai X; Na X; Kang Y; Wan L; Yang J
Biochem Pharmacol; 2021 Oct; 192():114671. PubMed ID: 34246626
[TBL] [Abstract][Full Text] [Related]
30. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of DX-9065a, an orally active, novel synthesized and selective inhibitor of factor Xa, against thromboplastin-induced experimental disseminated intravascular coagulation in rats.
Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
Semin Thromb Hemost; 1996; 22(3):255-9. PubMed ID: 8836010
[TBL] [Abstract][Full Text] [Related]
32. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
[TBL] [Abstract][Full Text] [Related]
34. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Tallman MS; Hakimian D; Kwaan HC; Rickles FR
Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
[TBL] [Abstract][Full Text] [Related]
35. [Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].
Lu X; Li W; Wang G; Wang Q; Jiang Y; Gao J; Zhao X; Xu L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):92-6. PubMed ID: 25665605
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
[TBL] [Abstract][Full Text] [Related]
37. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
38. Establishment of disseminated intravascular coagulation (DIC) model by a single iv administration of Escherichia coli-derived lipopolysaccharide (LPS) to cynomolgus monkeys and evaluation of its pathophysiological status.
Minomo H; Inoue K; Sakaki S; Okazaki T; Kobayashi K; Inoue K; Miyata A
J Pharmacol Sci; 2017 Feb; 133(2):88-95. PubMed ID: 28215474
[TBL] [Abstract][Full Text] [Related]
39. A case of ischemic stroke in acute promyelocytic leukemia at initial presentation. Relevance of all-trans retinoic acid treatment.
Carella AM; Antonucci G; Conte M; Di Pumpo M; Antonucci E; Ponziano E
Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):1-6. PubMed ID: 20041837
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
Ikezoe T
Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]